American Academy of Ophthalmology
On Friday 11th October, retinal ophthalmology expert Philip Hykin presented a major research paper to over 3000 retina specialists at the annual meeting of the American Acadaemy of Ophthalmology in San Francisco.
The paper – ‘A Multicenter Phase 3 Double-Masked Randomized Controlled Noninferiority Trial Comparing the Clinical and Cost Effectiveness of Lucentis vs. Eylea vs. Avastin in Macula Edema Due to Central Retinal Vein Occlusion (LEAVO)’ – offers ophthalmologists greater insight into the cost-effectiveness and efficacy of some of the most popular anti-VEGF treatments for patients with macular edema due to central retinal vein occlusion.
Search treatments & services A-Z
Search for a specific treatment or service.
In other news
Bupa unveils new world-class all-in-one centre in the heart of Canary Wharf
Bupa is proud to announce the unveiling of its new all-in-one health...
The benefits of continuous glucose monitoring
Living with diabetes – or with ongoing changes in your blood glucose...
Why managing diabetes means protecting your whole body
When you’re living with diabetes, it’s easy to focus on blood glucose...